MedPath

SALZMANN PRODUCT B-2 BIASOLT

SALZMANN PRODUCT B-2 BIASOLT

Discontinued
DIN Number

00696420

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

biocentre

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00696420
AIG Number0818318001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormPowder
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (8)

CALCIUM PHOSPHATE (TRIBASIC)Active
Strength: 2 X / X
Monograph: CALCIUM PHOSPHATE (TRIBASIC)
CUPRIC SULFATEActive
Strength: 6 X / X
Monograph: CUPRIC SULFATE
FERROUS GLUCONATEActive
Strength: 4 X / X
Monograph: FERROUS GLUCONATE
MAGNESIUM PHOSPHATE DIBASICActive
Strength: 6 X / X
Monograph: MAGNESIUM PHOSPHATE DIBASIC
POTASSIUM BICARBONATEActive
Strength: 2 X / X
Monograph: POTASSIUM BICARBONATE
POTASSIUM CHLORIDEActive
Strength: 2 X / X
Monograph: POTASSIUM CHLORIDE
POTASSIUM IODIDEActive
Strength: 5 X / X
Monograph: POTASSIUM IODIDE
POTASSIUM SULFATEActive
Strength: 6 X / X
Monograph: POTASSIUM SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.